Agent selectively targets malignant B cells in chronic leukemia, study shows
Tuesday, May 3, 2011 - 10:00
in Health & Medicine
A new experimental drug selectively kills the cancerous cells that cause chronic lymphocytic leukemia, according to a new study by researchers at the Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC James).